142 related articles for article (PubMed ID: 6293114)
1. Investigation of the effects of phospholipase C on human platelets: evidence that aggregation induced by phospholipase C is independent of prostaglandin generation, released ADP and is modulated by cyclic AMP.
Akbar H; Navran SS; Chang J; Miller DD; Feller DR
Thromb Res; 1982 Aug; 27(4):405-17. PubMed ID: 6293114
[TBL] [Abstract][Full Text] [Related]
2. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
Romstedt K; Huzoor-Akbar
Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
[TBL] [Abstract][Full Text] [Related]
3. Human platelet activation by bacterial phospholipase C is mediated by phosphatidylinositol hydrolysis but not generation of phosphatidic acid: inhibition by a selective inhibitor of phospholipase C.
Navran SS; Romstedt K; Chang J; Miller DD; Feller DR; Huzoor-Akbar
Thromb Res; 1984 Mar; 33(5):499-510. PubMed ID: 6372157
[TBL] [Abstract][Full Text] [Related]
4. Human platelet activation by bacterial phospholipase C: mechanism of inhibition by flurazepam.
Anwer K; Wallace D; Romstedt K; Huzoor-Akbar
Thromb Res; 1988 Jan; 49(2):225-39. PubMed ID: 2896397
[TBL] [Abstract][Full Text] [Related]
5. Phospholipase C from clostridium perfringens induces human platelet aggregation in plasma.
Barzaghi G; Cerletti C; de Gaetano G
Thromb Haemost; 1988 Apr; 59(2):236-9. PubMed ID: 2898818
[TBL] [Abstract][Full Text] [Related]
6. Platelet aggregation by a phospholipase C from Pseudomonas aeruginosa.
Coutinho IR; Berk RS; Mammen E
Thromb Res; 1988 Sep; 51(5):495-505. PubMed ID: 3140410
[TBL] [Abstract][Full Text] [Related]
7. Potentiating effects of clofibrate on prostaglandin-dependent and -independent pathways of human platelet activation: evidence for involvement of cyclic AMP.
Huzoor-Akbar ; Witiak DT; Newman HA; Fertel RH; Feller DR
Biochem Pharmacol; 1982 Jun; 31(11):2125-8. PubMed ID: 6288050
[TBL] [Abstract][Full Text] [Related]
8. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
9. Evidence that the rat is not an appropriate model to study the role of prostaglandins in normal or abnormal platelet aggregation.
Huzoor-Akbar ; Anwer K
Thromb Res; 1986 Feb; 41(4):555-66. PubMed ID: 3961734
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of human platelet activation by endotoxic glycolipid-bearing mutant Re595 of Salmonella minnesota.
Timmons S; Huzoor-Akbar ; Grabarek J; Kloczewiak M; Hawiger J
Blood; 1986 Nov; 68(5):1015-23. PubMed ID: 3768528
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
Haslam RJ; Davidson MM; Desjardins JV
Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
[TBL] [Abstract][Full Text] [Related]
12. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
Salzman EW
Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
[TBL] [Abstract][Full Text] [Related]
13. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
14. Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid.
Packham MA; Livne AA; Ruben DH; Rand ML
Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):849-56. PubMed ID: 8384448
[TBL] [Abstract][Full Text] [Related]
15. Investigation of cyclooxygenase and signaling pathways involved in human platelet aggregation mediated by synergistic interaction of various agonists.
Khan N; Farooq AD; Sadek B
Drug Des Devel Ther; 2015; 9():3497-506. PubMed ID: 26185418
[TBL] [Abstract][Full Text] [Related]
16. On the interrelationship of prostaglandin endoperoxide G2 and cyclic nucleotides in platelet function.
Claesson HE; Malmsten C
Eur J Biochem; 1977 Jun; 76(1):277-84. PubMed ID: 195812
[TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine.
Dhar A; Paul AK; Shukla SD
Mol Pharmacol; 1990 Apr; 37(4):519-25. PubMed ID: 1691437
[TBL] [Abstract][Full Text] [Related]
18. The naphthoquinone plumbagin suppresses ADP-induced rat platelet aggregation through P2Y1-PLC signaling pathway.
Zhang Q; Liao X; Wu F
Pak J Pharm Sci; 2017 Mar; 30(2(Suppl.)):573-578. PubMed ID: 28650323
[TBL] [Abstract][Full Text] [Related]
19. The role of platelet membrane phospholipids in the platelet release reaction.
Schick PK; Yu BP
J Clin Invest; 1974 Nov; 54(5):1032-9. PubMed ID: 4371563
[TBL] [Abstract][Full Text] [Related]
20. Arachidonic acid-induced human platelet aggregation independent of cyclooxygenase and lipoxygenase.
Maclouf J; Levy-Toledano S; Savariau E; Hardisty R; Caen JP
Prostaglandins; 1984 Sep; 28(3):383-98. PubMed ID: 6440214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
